Founded in 2012 and based in New York, Pura Vida Investments is a market-neutral investment vehicle that capitalizes on structural changes in the healthcare industry. Led by Efrem Kamen and Doron Junger MD, the fund invests in various healthcare sectors, including medical devices, biotechnology, pharmaceuticals, and healthcare services. With a preference for startups aged 6-10 years, Pura Vida Investments typically participates in investment rounds with 7-8 other investors. The fund has a track record of generating superior returns and was recognized as the Best Emerging Manager in Global Equities in 2018.